Phenylacetate and brain dysfunction in experimental phenylketonuria: synaptic development.
D000818:Animals; D002540:Cerebral Cortex / Q000032:analysis; D002794:Choline / Q000378:metabolism; D005260:Female; D010134:Fenclonine; D006801:Humans; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D010648:Phenylacetates / Q000494:pharmacology*; D010649:Phenylalanine / Q000494:pharmacology*; D010661:Phenylketonurias / Q000139:chemically induced / Q000503:physiopathology*; D011247:Pregnancy; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D012794:Sialic Acids / Q000032:analysis; D013574:Synaptosomes / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D018377:Neurotransmitter Agents; D010627:Phenethylamines; D010648:Phenylacetates; D012794:Sialic Acids; D012701:Serotonin; D010649:Phenylalanine; D005680:gamma-Aminobutyric Acid; D002794:Choline; D010134:Fenclonine; D009638:Norepinephrine